Sign in
4

Changes in Ownership

TransMedics Group, Inc. Filed Acc 0000950170-24-013458

Chief Commercial Officer sold 736 shares at $90.09 ($66,306)

  • Chief Commercial Officer acquired 736 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Khayal Tamer I · Chief Commercial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-02-07 Exercise or conversion : show line 1 in the form 10b5-1 +736 $16.00 $11,776 15,111 D
2024-02-07 Sale : show line 2 in the form 10b5-1 −736 $90.09 $66,306 14,375 D
Open-market sales · 736 sh · avg $90.09 · $66,306

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-02-07 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) −736 4,970 D
Loading xslF345X05/ownership.xml…